Safety of liquid intravenous immunoglobulin for neuroimmunologic disorders in the home setting: a retrospective analysis of 1085 infusions.
about
Management of acute exacerbations in multiple sclerosis.Use of intravenous immunoglobulin in the Department of Neurology at Ninewells Hospital, 2008-2009: Indications for utilization and cost-effectiveness.Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosisNew insights into the management of chronic inflammatory demyelinating polyradiculoneuropathy.10% liquid human immunoglobulin (KIOVIG(®)) for immunomodulation in autoimmune disorders.Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French Study.
P2860
Safety of liquid intravenous immunoglobulin for neuroimmunologic disorders in the home setting: a retrospective analysis of 1085 infusions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety of liquid intravenous i ...... ve analysis of 1085 infusions.
@en
Safety of liquid intravenous i ...... ve analysis of 1085 infusions.
@nl
type
label
Safety of liquid intravenous i ...... ve analysis of 1085 infusions.
@en
Safety of liquid intravenous i ...... ve analysis of 1085 infusions.
@nl
prefLabel
Safety of liquid intravenous i ...... ve analysis of 1085 infusions.
@en
Safety of liquid intravenous i ...... ve analysis of 1085 infusions.
@nl
P2093
P1476
Safety of liquid intravenous i ...... ve analysis of 1085 infusions.
@en
P2093
Michael Rigas
Robert J Sterling
Rup Tandan
P356
10.1097/CND.0B013E31818B2AEF
P577
2008-12-01T00:00:00Z